Impact of Chronic Kidney Disease on Periprocedural Anticoagulation and Short-Term Outcomes after TAVR: A BRAVO-3 Trial SubanalysisVictor Razuk, George Dangas, Davide Cao et al.|SSRN Electronic Journal|2021Cited by 0